Alligator Bioscience — Share Issue/Capital Change 2026

Mar 31, 2026

PRESS RELEASE
31 March 2026 15:00:00 CEST
ALLIGATOR bioscience

CHANGE IN NUMBER OF SHARES AND VOTES IN ALLIGATOR BIOSCIENCE AB

During March 2026, the number of shares and votes in Alligator Bioscience AB ("Alligator Bioscience") has increased as a result of the exercise of warrants series TO 14, issued in connection with the rights issue of units carried out during October – December 2025.

As of 31 March 2026, the total number of outstanding shares and votes in Alligator Bioscience amounts to 628,106,848, whereof all outstanding shares are ordinary shares with one vote each.

For further information, please contact:

Søren Bregenholt, CEO
E-mail: soren.bregenholt@alligatorbioscience.com
Phone: +46 (0) 46 540 82 00

This information is information that Alligator Bioscience is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication at 2026-03-31 15:00 CEST.

Attachments

Change in number of shares and votes in Alligator Bioscience AB

Alligator Bioscience
•
Medicon Village
•
SE-223 81 Lund